Analisi etica in un processo HTA di dolutegravir

Translated title of the contribution: [Autom. eng. transl.] Ethical analysis in a dolutegravir HTA process

Research output: Contribution to journalArticlepeer-review

Abstract

[Autom. eng. transl.] In the treatment of HIV-1 infection, the need to improve adherence to treatment (reducing the number of doses and the use of boosters) and to minimize the phenomenon of resistance to mutations in the gene that codes for the enzyme integrase, led to the development of the new drug dolutegravir (DTG), the subject of this ethical evaluation in HTA (Health Technology Assessment).
Translated title of the contribution[Autom. eng. transl.] Ethical analysis in a dolutegravir HTA process
Original languageItalian
Pages (from-to)99-103
Number of pages5
JournalItalian Journal of Public Health
Volume3
Publication statusPublished - 2014

Keywords

  • HTA
  • Infezione da HIV-1
  • Inibitori della integrasi
  • etica

Fingerprint

Dive into the research topics of '[Autom. eng. transl.] Ethical analysis in a dolutegravir HTA process'. Together they form a unique fingerprint.

Cite this